Pfizer and BioNTech win bid to invalidate CureVac’s COVID vaccine patents in UK

Pfizer and its partner BioNTech won their bid to invalidate CureVac’s COVID vaccine patents in the High Court in London. Pfizer and BioNTech had filed their lawsuit in September 2022 over patents related to messenger RNA technology.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM